{"id":2278,"date":"2021-03-05T00:00:00","date_gmt":"2021-03-05T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2278"},"modified":"2021-03-05T00:00:00","modified_gmt":"2021-03-05T00:00:00","slug":"centogene%e5%9c%a8%e5%85%a8%e7%90%83%e5%b8%95%e9%87%91%e6%a3%ae%e7%97%85%e7%a0%94%e7%a9%b6%e4%b8%ad%e8%be%be%e5%88%b010000%e5%90%8d%e5%8f%82%e4%b8%8e%e8%80%85%e7%9a%84%e9%87%8c%e7%a8%8b%e7%a2%91","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/zh\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\/","title":{"rendered":"CENTOGENE\u5168\u7403\u5e15\u91d1\u68ee\u75c5\u7814\u7a76\u53c2\u4e0e\u8005\u4eba\u6570\u7a81\u783410000\u4eba"},"content":{"rendered":"<p>\u7f8e\u56fd\u9a6c\u8428\u8bf8\u585e\u5dde\u5251\u6865\u3001\u5fb7\u56fd\u7f57\u65af\u6258\u514b\u548c\u67cf\u6797\uff0c2021\u5e743\u67089\u65e5\uff08\u73af\u7403\u901a\u8baf\u793e\uff09<\/p>\n<ul>\n<li>\u7f57\u65af\u6258\u514b\u56fd\u9645\u5e15\u91d1\u68ee\u75c5\uff08ROPAD\uff09\u7814\u7a76\u65e8\u5728\u9610\u660e\u5e15\u91d1\u68ee\u75c5\u7684\u9057\u4f20\u7279\u5f81\uff0c\u4ee5\u66f4\u597d\u5730\u4e86\u89e3\u8be5\u75be\u75c5\u7684\u8fdb\u5c55\u3001\u8bca\u65ad\u548c\u6cbb\u7597\u3002<\/li>\n<li>\u53c2\u4e0e\u4eba\u6570\u7a81\u783410000\u4eba\uff0c\u8fbe\u6210\u91cd\u8981\u91cc\u7a0b\u7891<\/li>\n<li>CENTOGENE\u5728\u5168\u7403\u62e5\u6709\u8d85\u8fc7120\u4e2a\u7814\u7a76\u4e2d\u5fc3\uff0c\u6b63\u5728\u5f00\u5c55\u8fc4\u4eca\u4e3a\u6b62\u89c4\u6a21\u6700\u5927\u7684\u5e15\u91d1\u68ee\u75c5\u9057\u4f20\u5b66\u76f8\u5173\u7814\u7a76\u3002<\/li>\n<\/ul>\n<p>\u4e13\u6ce8\u4e8e\u7f55\u89c1\u75c5\u9886\u57df\u7684\u5546\u4e1a\u5316\u9636\u6bb5\u516c\u53f8Centogene NV\uff08\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u4ee3\u7801\uff1aCNTG\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u5176\u7f57\u65af\u6258\u514b\u56fd\u9645\u5e15\u91d1\u68ee\u75c5\uff08ROPAD\uff09\u7814\u7a76\u53d6\u5f97\u91cd\u5927\u91cc\u7a0b\u7891\u5f0f\u8fdb\u5c55\uff0c\u5df2\u5b8c\u621010,000\u540d\u53c2\u4e0e\u8005\u7684\u62db\u52df\u548c\u57fa\u56e0\u68c0\u6d4b\u3002Centogene NV\u81f4\u529b\u4e8e\u5c06\u771f\u5b9e\u4e16\u754c\u7684\u4e34\u5e8a\u548c\u57fa\u56e0\u6570\u636e\u8f6c\u5316\u4e3a\u53ef\u4f9b\u60a3\u8005\u3001\u533b\u751f\u548c\u5236\u836f\u516c\u53f8\u4f7f\u7528\u7684\u53ef\u64cd\u4f5c\u4fe1\u606f\uff0c\u5e76\u5c06\u8fd9\u4e9b\u6570\u636e\u8f6c\u5316\u4e3a\u5b9e\u9645\u5e94\u7528\u3002CENTOGENE\u7275\u5934\u5f00\u5c55\u7684ROPAD\u7814\u7a76\u662f\u540c\u7c7b\u7814\u7a76\u4e2d\u89c4\u6a21\u6700\u5927\u7684\uff0c\u6db5\u76d6\u5168\u7403120\u591a\u4e2a\u7814\u7a76\u4e2d\u5fc3\uff0c\u662f\u4e00\u9879\u5168\u7403\u89c2\u5bdf\u6027\u7814\u7a76\uff0c\u65e8\u5728\u63a2\u7a76\u9057\u4f20\u56e0\u7d20\u5728\u5e15\u91d1\u68ee\u75c5\uff08PD\uff09\u4e2d\u7684\u4f5c\u7528\u3002.<\/p>\n<p>CENTOGENE\u9996\u5e2d\u57fa\u56e0\u7ec4\u5b98Peter Bauer\u6559\u6388\u8868\u793a\uff1a\u201c\u6211\u4eec\u5f88\u9ad8\u5174\u5e15\u91d1\u68ee\u75c5\u7814\u7a76\u53d6\u5f97\u4e86\u5982\u6b64\u5173\u952e\u7684\u8fdb\u5c55\u3002\u4e34\u5e8a\u7814\u7a76\u5f80\u5f80\u7f3a\u4e4f\u8db3\u591f\u7684\u79cd\u65cf\u591a\u6837\u6027\uff0c\u800c\u6211\u4eec\u5f88\u81ea\u8c6a\u8fd9\u9879\u7814\u7a76\u7eb3\u5165\u4e86\u6765\u81ea\u4e16\u754c\u5404\u5730\u76841\u4e07\u591a\u540d\u53c2\u4e0e\u8005\u3002\u5c55\u671b\u672a\u6765\uff0c\u6211\u4eec\u5e0c\u671b\u5229\u7528\u8fd9\u4e9b\u5bf9\u5e15\u91d1\u68ee\u75c5\u9057\u4f20\u5b66\u7684\u6df1\u523b\u89c1\u89e3\uff0c\u5c3d\u65e9\u8bca\u65ad\u60a3\u8005\uff0c\u5e76\u4e3a\u5e15\u91d1\u68ee\u75c5\u7684\u9776\u5411\u6cbb\u7597\u505a\u51fa\u8d21\u732e\u3002\u201d<\/p>\n<p>2018\u5e74\uff0cCENTOGENE\u4e0eDenali Therapeutics\u8fbe\u6210\u6218\u7565\u5408\u4f5c\uff0c\u65e8\u5728\u9488\u5bf9\u5168\u7403\u5e15\u91d1\u68ee\u75c5\u60a3\u8005\uff0c\u5f00\u5c55LRRK2\u57fa\u56e0\u7a81\u53d8\u7684\u9776\u5411\u8bc6\u522b\u548c\u62db\u52df\u5de5\u4f5c\u3002LRRK2\u57fa\u56e0\u7a81\u53d8\u662f\u5e15\u91d1\u68ee\u75c5\u6700\u5e38\u89c1\u7684\u9057\u4f20\u75c5\u56e0\u4e4b\u4e00\u3002\u53c2\u4e0eROPAD\u7814\u7a76\u4e14\u643a\u5e26LRRK2\u57fa\u56e0\u7a81\u53d8\u7684\u60a3\u8005\uff0c\u672a\u6765\u53ef\u80fd\u7b26\u5408\u53c2\u4e0e\u5176\u4ed6\u6cbb\u7597\u6027\u4e34\u5e8a\u7814\u7a76\u7684\u6761\u4ef6\uff0c\u5305\u62ec\u4e0eDenali Therapeutics\u5408\u4f5c\u5f00\u5c55\u7684\u7814\u7a76\u3002Denali Therapeutics\u6b63\u4e0eBiogen\u5408\u4f5c\u5f00\u53d1\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u5e15\u91d1\u68ee\u75c5\u7684\u5c0f\u5206\u5b50LRRK2\u6291\u5236\u5242\u3002.<\/p>\n<h2 class=\"h3\">\u5173\u4e8e ROPAD<\/h2>\n<p>\u7f57\u65af\u6258\u514b\u56fd\u9645\u5e15\u91d1\u68ee\u75c5\u7814\u7a76\uff08ROPAD\uff09\u662f\u4e00\u9879\u5168\u7403\u6d41\u884c\u75c5\u5b66\u7814\u7a76\uff0c\u91cd\u70b9\u5173\u6ce8\u9057\u4f20\u56e0\u7d20\u5728\u5e15\u91d1\u68ee\u75c5\uff08PD\uff09\u4e2d\u7684\u4f5c\u7528\u3002\u8be5\u7814\u7a76\u7684\u4e3b\u8981\u76ee\u6807\u662f\u9610\u660e\u5e15\u91d1\u68ee\u75c5\u7684\u9057\u4f20\u7279\u5f81\uff0c\u4ece\u800c\u66f4\u597d\u5730\u4e86\u89e3\u8be5\u75c5\u7684\u75c5\u56e0\u3001\u8bca\u65ad\u548c\u4e25\u91cd\u7a0b\u5ea6\u3002.<\/p>\n<p>CENTOGENE\u516c\u53f8\u5229\u7528\u5176\u4e13\u6709\u7684\u3001\u83b7\u5f97CE\u8ba4\u8bc1\u7684\u5e72\u8840\u6591\u91c7\u96c6\u8bd5\u5242\u76d2CentoCard\u00ae\uff0c\u7ed3\u5408\u6700\u5148\u8fdb\u7684\u6d4b\u5e8f\u6280\u672f\uff0c\u7b5b\u67e5LRRK2\u57fa\u56e0\u548c\u5176\u4ed6\u5e15\u91d1\u68ee\u75c5\u76f8\u5173\u57fa\u56e0\u7684\u7a81\u53d8\u3002\u5728\u8fd9\u9879\u7814\u7a76\u4e2d\uff0c\u6765\u81ea\u4e16\u754c\u5404\u5730\u768410,000\u540d\u53c2\u4e0e\u8005\u5728\u4e24\u5e74\u5185\u63a5\u53d7\u4e86\u68c0\u6d4b\u3002.<\/p>\n<p>\u643a\u5e26\u5e15\u91d1\u68ee\u75c5\u57fa\u56e0\u7a81\u53d8\u7684\u60a3\u8005\u5c06\u6709\u673a\u4f1a\u53c2\u4e0e\u4e00\u9879\u540d\u4e3a\u2018\u5415\u8d1d\u514b\u56fd\u9645\u5e15\u91d1\u68ee\u75c5\u9879\u76ee\uff08LIPAD\uff09\u2019\u7684\u8865\u5145\u7814\u7a76\uff0c\u63a5\u53d7\u8fdb\u4e00\u6b65\u7684\u4e34\u5e8a\u8bc4\u4f30\u3002\u8be5\u7814\u7a76\u7531\u5415\u8d1d\u514b\u5927\u5b66\u5f00\u5c55\uff0c\u5c06\u5bf9\u53c2\u4e0e\u8005\u8fdb\u884c\u8be6\u7ec6\u7684\u8868\u578b\u5206\u6790\u3002\u53c2\u4e0e\u8005\u672a\u6765\u53ef\u80fd\u88ab\u9080\u8bf7\u53c2\u4e0e\u5176\u4ed6\u5e72\u9884\u6027\u4e34\u5e8a\u7814\u7a76\uff0c\u5305\u62ec\u4e0e\u7814\u7a76\u5408\u4f5c\u4f19\u4f34Denali Therapeutics\u5408\u4f5c\u5f00\u5c55\u7684\u7814\u7a76\u3002Denali Therapeutics\u6b63\u4e0eBiogen\u5408\u4f5c\u5f00\u53d1\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u5e15\u91d1\u68ee\u75c5\u7684\u5c0f\u5206\u5b50LRRK2\u6291\u5236\u5242\u3002.<\/p>\n<p>ROPAD \u7814\u7a76\u65b9\u6848\u548c\u521d\u6b65\u7814\u7a76\u7ed3\u679c\u8fd1\u671f\u5df2\u53d1\u8868\u4e8e\u2026\u2026 <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33314351\/\" target=\"_blank\" title=\"\u67e5\u770b\u8be5\u7814\u7a76\">\u8fd0\u52a8\u969c\u788d\u6742\u5fd7\u3002.<\/a><\/p>\n<h3>\u5173\u4e8e CENTOGENE<\/h3>\n<p>CENTOGENE\u81f4\u529b\u4e8e\u7f55\u89c1\u75c5\u7684\u8bca\u65ad\u548c\u7814\u7a76\uff0c\u5c06\u771f\u5b9e\u4e16\u754c\u7684\u4e34\u5e8a\u548c\u9057\u4f20\u6570\u636e\u8f6c\u5316\u4e3a\u53ef\u4f9b\u60a3\u8005\u3001\u533b\u751f\u548c\u5236\u836f\u516c\u53f8\u4f7f\u7528\u7684\u5b9e\u7528\u4fe1\u606f\u3002\u6211\u4eec\u7684\u76ee\u6807\u662f\u5229\u7528\u6211\u4eec\u4e30\u5bcc\u7684\u7f55\u89c1\u75c5\u77e5\u8bc6\uff08\u5305\u62ec\u6d41\u884c\u75c5\u5b66\u548c\u4e34\u5e8a\u6570\u636e\u4ee5\u53ca\u521b\u65b0\u751f\u7269\u6807\u5fd7\u7269\uff09\uff0c\u4f7f\u6cbb\u7597\u51b3\u7b56\u66f4\u52a0\u5408\u7406\uff0c\u5e76\u52a0\u901f\u65b0\u578b\u5b64\u513f\u836f\u7684\u7814\u53d1\u3002\u622a\u81f32020\u5e749\u670830\u65e5\uff0cCENTOGENE\u5df2\u57fa\u4e8e\u6211\u4eec\u62e5\u6709\u8d85\u8fc736\u4ebf\u4e2a\u52a0\u6743\u6570\u636e\u70b9\u7684\u771f\u5b9e\u4e16\u754c\u6570\u636e\u5b58\u50a8\u5e93\uff0c\u5f00\u53d1\u4e86\u4e00\u4e2a\u5168\u7403\u4e13\u6709\u7684\u7f55\u89c1\u75c5\u5e73\u53f0\uff0c\u8fd9\u4e9b\u6570\u636e\u70b9\u6765\u81ea\u6765\u81ea120\u591a\u4e2a\u56fd\u5bb6\/\u5730\u533a\u7684\u7ea659.5\u4e07\u540d\u60a3\u8005\u3002.<\/p>\n<p>\u516c\u53f8\u5e73\u53f0\u5305\u542b\u53cd\u6620\u5168\u7403\u4eba\u7fa4\u7684\u6d41\u884c\u75c5\u5b66\u3001\u8868\u578b\u548c\u9057\u4f20\u6570\u636e\uff0c\u4ee5\u53ca\u8fd9\u4e9b\u60a3\u8005\u8840\u6db2\u6837\u672c\u7684\u751f\u7269\u6837\u672c\u5e93\u3002CENTOGENE \u8ba4\u4e3a\uff0c\u8fd9\u662f\u552f\u4e00\u80fd\u591f\u5168\u9762\u5206\u6790\u591a\u5c42\u6b21\u6570\u636e\u7684\u5e73\u53f0\uff0c\u6709\u52a9\u4e8e\u52a0\u6df1\u5bf9\u7f55\u89c1\u9057\u4f20\u75c5\u7684\u7406\u89e3\uff0c\u4ece\u800c\u5e2e\u52a9\u8bc6\u522b\u60a3\u8005\uff0c\u5e76\u63d0\u5347\u6211\u4eec\u5236\u836f\u5408\u4f5c\u4f19\u4f34\u5c06\u5b64\u513f\u836f\u63a8\u5411\u5e02\u573a\u7684\u80fd\u529b\u3002\u622a\u81f3 2020 \u5e74 9 \u6708 30 \u65e5\uff0c\u516c\u53f8\u5df2\u4e0e 40 \u591a\u5bb6\u5236\u836f\u5408\u4f5c\u4f19\u4f34\u5f00\u5c55\u5408\u4f5c\uff0c\u6db5\u76d6 45 \u79cd\u4ee5\u4e0a\u7684\u4e0d\u540c\u7f55\u89c1\u75c5\u3002.<\/p>\n<h5><strong>\u91cd\u8981\u901a\u77e5\u548c\u514d\u8d23\u58f0\u660e<\/strong><\/h5>\n<p>\u672c\u65b0\u95fb\u7a3f\u5305\u542b\u6784\u62101995\u5e74\u7f8e\u56fd\u300a\u79c1\u4eba\u8bc1\u5238\u8bc9\u8bbc\u6539\u9769\u6cd5\u6848\u300b\u6240\u5b9a\u4e49\u7684\u201c\u524d\u77bb\u6027\u9648\u8ff0\u201d\u7684\u5185\u5bb9\uff0c\u5305\u62ec\u8868\u8fbe\u516c\u53f8\u5bf9\u672a\u6765\u4e8b\u4ef6\u6216\u672a\u6765\u4e1a\u7ee9\u7684\u610f\u89c1\u3001\u9884\u671f\u3001\u4fe1\u5ff5\u3001\u8ba1\u5212\u3001\u76ee\u6807\u3001\u5047\u8bbe\u6216\u9884\u6d4b\u7684\u9648\u8ff0\uff0c\u8fd9\u4e9b\u9648\u8ff0\u4e0e\u53cd\u6620\u5386\u53f2\u4e8b\u5b9e\u7684\u9648\u8ff0\u5f62\u6210\u5bf9\u6bd4\u3002\u4f8b\u5982\uff0c\u5173\u4e8e\u6211\u4eec\u7684\u6218\u7565\u3001\u878d\u8d44\u8ba1\u5212\u3001\u589e\u957f\u673a\u4f1a\u548c\u5e02\u573a\u589e\u957f\u7684\u8ba8\u8bba\u3002\u5728\u67d0\u4e9b\u60c5\u51b5\u4e0b\uff0c\u60a8\u53ef\u4ee5\u901a\u8fc7\u8bf8\u5982\u201c\u9884\u671f\u201d\u3001\u201c\u6253\u7b97\u201d\u3001\u201c\u76f8\u4fe1\u201d\u3001\u201c\u4f30\u8ba1\u201d\u3001\u201c\u8ba1\u5212\u201d\u3001\u201c\u5bfb\u6c42\u201d\u3001\u201c\u9884\u6d4b\u201d\u6216\u201c\u671f\u671b\u201d\u3001\u201c\u53ef\u80fd\u201d\u3001\u201c\u5c06\u201d\u3001\u201c\u4f1a\u201d\u3001\u201c\u53ef\u4ee5\u201d\u6216\u201c\u5e94\u8be5\u201d\u7b49\u8bcd\u8bed\uff0c\u4ee5\u53ca\u8fd9\u4e9b\u8bcd\u8bed\u7684\u5426\u5b9a\u5f62\u5f0f\u6216\u7c7b\u4f3c\u8868\u8fbe\u6765\u8bc6\u522b\u6b64\u7c7b\u524d\u77bb\u6027\u9648\u8ff0\u3002\u524d\u77bb\u6027\u9648\u8ff0\u57fa\u4e8e\u7ba1\u7406\u5c42\u5f53\u524d\u7684\u4fe1\u5ff5\u548c\u5047\u8bbe\u4ee5\u53ca\u516c\u53f8\u76ee\u524d\u53ef\u83b7\u5f97\u7684\u4fe1\u606f\u3002\u7136\u800c\uff0c\u8fd9\u4e9b\u524d\u77bb\u6027\u9648\u8ff0\u5e76\u975e\u5bf9\u6211\u4eec\u4e1a\u7ee9\u7684\u4fdd\u8bc1\uff0c\u60a8\u4e0d\u5e94\u8fc7\u5206\u4f9d\u8d56\u6b64\u7c7b\u9648\u8ff0\u3002\u524d\u77bb\u6027\u9648\u8ff0\u53d7\u8bf8\u591a\u98ce\u9669\u3001\u4e0d\u786e\u5b9a\u6027\u53ca\u5176\u4ed6\u53ef\u53d8\u56e0\u7d20\u7684\u5f71\u54cd\uff0c\u4f8b\u5982\u5168\u7403\u7ecf\u6d4e\u5f62\u52bf\u4e0d\u4f73\u3001\u5168\u7403\u91d1\u878d\u5e02\u573a\u6301\u7eed\u52a8\u8361\u3001\u65b0\u51a0\u75ab\u60c5\u5bf9\u6211\u4eec\u4e1a\u52a1\u53ca\u7ecf\u8425\u4e1a\u7ee9\u7684\u5f71\u54cd\u3001\u73b0\u884c\u53ca\u62df\u8bae\u7684\u6cd5\u5f8b\u6cd5\u89c4\u548c\u653f\u5e9c\u653f\u7b56\u53ef\u80fd\u53d1\u751f\u7684\u53d8\u5316\u3001\u884c\u4e1a\u7ade\u4e89\u52a0\u5267\u548c\u6574\u5408\u5e26\u6765\u7684\u538b\u529b\u3001\u76d1\u7ba1\u5ba1\u6279\uff08\u5305\u62ec\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u7684\u5ba1\u6279\uff09\u7684\u6210\u672c\u548c\u4e0d\u786e\u5b9a\u6027\u3001\u6211\u4eec\u5bf9\u7b2c\u4e09\u65b9\u53ca\u5408\u4f5c\u4f19\u4f34\u7684\u4f9d\u8d56\uff08\u5305\u62ec\u6211\u4eec\u7ba1\u7406\u589e\u957f\u548c\u5efa\u7acb\u65b0\u5ba2\u6237\u5173\u7cfb\u7684\u80fd\u529b\uff09\u3001\u6211\u4eec\u5bf9\u7f55\u89c1\u75c5\u884c\u4e1a\u7684\u4f9d\u8d56\u3001\u6211\u4eec\u7ba1\u7406\u56fd\u9645\u6269\u5f20\u7684\u80fd\u529b\u3001\u6211\u4eec\u5bf9\u5173\u952e\u4eba\u5458\u7684\u4f9d\u8d56\u3001\u6211\u4eec\u5bf9\u77e5\u8bc6\u4ea7\u6743\u4fdd\u62a4\u7684\u4f9d\u8d56\u3001\u6c47\u7387\u6ce2\u52a8\u6216\u5176\u4ed6\u56e0\u7d20\u5bfc\u81f4\u7684\u7ecf\u8425\u4e1a\u7ee9\u6ce2\u52a8\u3002\u6b64\u7c7b\u98ce\u9669\u548c\u4e0d\u786e\u5b9a\u6027\u53ef\u80fd\u5bfc\u81f4\u9648\u8ff0\u4e0d\u51c6\u786e\uff0c\u656c\u8bf7\u8bfb\u8005\u4e0d\u8981\u8fc7\u5206\u4f9d\u8d56\u6b64\u7c7b\u9648\u8ff0\u3002\u5176\u4e2d\u8bb8\u591a\u98ce\u9669\u8d85\u51fa\u672c\u516c\u53f8\u7684\u63a7\u5236\u8303\u56f4\uff0c\u53ef\u80fd\u5bfc\u81f4\u672c\u516c\u53f8\u7684\u5b9e\u9645\u4e1a\u7ee9\u4e0e\u9884\u671f\u4e1a\u7ee9\u5b58\u5728\u91cd\u5927\u5dee\u5f02\u3002\u672c\u65b0\u95fb\u7a3f\u4e2d\u5305\u542b\u7684\u524d\u77bb\u6027\u9648\u8ff0\u4ec5\u4ee3\u8868\u622a\u81f3\u53d1\u5e03\u4e4b\u65e5\u7684\u4fe1\u606f\u3002\u9664\u6cd5\u5f8b\u53e6\u6709\u89c4\u5b9a\u5916\uff0c\u672c\u516c\u53f8\u4e0d\u627f\u62c5\u4efb\u4f55\u66f4\u65b0\u6b64\u7c7b\u9648\u8ff0\u6216\u516c\u5f00\u5ba3\u5e03\u5bf9\u6b64\u7c7b\u9648\u8ff0\u8fdb\u884c\u4efb\u4f55\u4fee\u8ba2\u4ee5\u53cd\u6620\u672a\u6765\u4e8b\u4ef6\u6216\u53d1\u5c55\u7684\u4e49\u52a1\uff0c\u5e76\u7279\u6b64\u58f0\u660e\u62d2\u7edd\u627f\u62c5\u6b64\u7c7b\u4e49\u52a1\u3002.<\/p>\n<p>\u5982\u9700\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u53c2\u9605\u6211\u4eec\u4e8e2020\u5e744\u670823\u65e5\u5411\u7f8e\u56fd\u8bc1\u5238\u4ea4\u6613\u59d4\u5458\u4f1a\uff08SEC\uff09\u63d0\u4ea4\u7684\u622a\u81f32019\u5e7412\u670831\u65e5\u6b62\u5e74\u5ea6\u768420-F\u8868\u683c\u5e74\u5ea6\u62a5\u544a\u4e2d\u7684\u201c\u98ce\u9669\u56e0\u7d20\u201d\u90e8\u5206\uff1b\u4e8e2020\u5e746\u670815\u65e5\u5411SEC\u63d0\u4ea4\u7684\u5305\u542b\u622a\u81f32020\u5e743\u670831\u65e5\u6b62\u4e09\u4e2a\u6708\u8d22\u52a1\u4e1a\u7ee9\u76846-K\u8868\u683c\uff1b\u4e8e2020\u5e7412\u670816\u65e5\u5411SEC\u63d0\u4ea4\u7684\u5305\u542b\u622a\u81f32020\u5e749\u670830\u65e5\u6b62\u4e09\u4e2a\u6708\u548c\u4e5d\u4e2a\u6708\u8d22\u52a1\u4e1a\u7ee9\u76846-K\u8868\u683c\uff1b\u4ee5\u53ca\u6211\u4eec\u5411\u7f8e\u56fd\u8bc1\u5238\u4ea4\u6613\u59d4\u5458\u4f1a\uff08SEC\uff09\u63d0\u4ea4\u6216\u63d0\u4f9b\u7684\u5176\u4ed6\u6700\u65b0\u62a5\u544a\u548c\u6587\u4ef6\u3002\u60a8\u53ef\u4ee5\u901a\u8fc7\u8bbf\u95eeEDGAR\u7cfb\u7edf\u83b7\u53d6\u8fd9\u4e9b\u6587\u4ef6\u3002 <a href=\"http:\/\/www.sec.gov\" target=\"_blank\" title=\"\u94fe\u63a5\u81f3\u7f8e\u56fd\u8bc1\u5238\u4ea4\u6613\u59d4\u5458\u4f1a\u7f51\u7ad9\">\u5728 SEC \u7f51\u7ad9\u4e0a<\/a>.<\/p>\n<h5>\u5a92\u4f53\u8054\u7cfb\u4eba\uff1a<strong> <\/strong><\/h5>\n<p>\u4e2d\u5fc3\u57fa\u56e0<br \/> \u672c\u00b7\u83b1\u683c<br \/> \u4f01\u4e1a\u4f20\u64ad\u90e8<br \/> <a href=\"mailto:press@centogene.com\" title=\"\u5199\u4e00\u5c01\u7535\u5b50\u90ae\u4ef6\">press@centogene.com<\/a><\/p>\n<p> FTI\u54a8\u8be2\u516c\u53f8<strong> <\/strong><br \/> \u5e03\u91cc\u8fea\u00b7\u52b3\u52d2\u00b7\u5965\u535a\u4f0a\u5c14<br \/> +1.917.929.5684<br \/> <a href=\"mailto:bridie.lawlor@fticonsulting.com\" title=\"\u5199\u4e00\u5c01\u7535\u5b50\u90ae\u4ef6\">bridie.lawlor@fticonsulting.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 9, 2021 (GLOBE NEWSWIRE) Rostock International Parkinson&#8217;s Disease (ROPAD) Study aims to [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2278","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CENTOGENE Reaches 10,000 Participant Milestone in Global Parkinson\u2019s Disease Study | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/zh\/centogene\u5728\u5168\u7403\u5e15\u91d1\u68ee\u75c5\u7814\u7a76\u4e2d\u8fbe\u523010000\u540d\u53c2\u4e0e\u8005\u7684\u91cc\u7a0b\u7891\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE Reaches 10,000 Participant Milestone in Global Parkinson\u2019s Disease Study | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 9, 2021 (GLOBE NEWSWIRE) Rostock International Parkinson&#8217;s Disease (ROPAD) Study aims to [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/zh\/centogene\u5728\u5168\u7403\u5e15\u91d1\u68ee\u75c5\u7814\u7a76\u4e2d\u8fbe\u523010000\u540d\u53c2\u4e0e\u8005\u7684\u91cc\u7a0b\u7891\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-05T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE Reaches 10,000 Participant Milestone in Global Parkinson\u2019s Disease Study\",\"datePublished\":\"2021-03-05T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\\\/\"},\"wordCount\":1179,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\\\/\",\"name\":\"CENTOGENE Reaches 10,000 Participant Milestone in Global Parkinson\u2019s Disease Study | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2021-03-05T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE Reaches 10,000 Participant Milestone in Global Parkinson\u2019s Disease Study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/zh\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE\u5168\u7403\u5e15\u91d1\u68ee\u75c5\u7814\u7a76\u53c2\u4e0e\u8005\u4eba\u6570\u7a81\u78341\u4e07\u5927\u5173 | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/zh\/centogene\u5728\u5168\u7403\u5e15\u91d1\u68ee\u75c5\u7814\u7a76\u4e2d\u8fbe\u523010000\u540d\u53c2\u4e0e\u8005\u7684\u91cc\u7a0b\u7891\/","og_locale":"zh_CN","og_type":"article","og_title":"CENTOGENE Reaches 10,000 Participant Milestone in Global Parkinson\u2019s Disease Study | CENTOGENE","og_description":"CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 9, 2021 (GLOBE NEWSWIRE) Rostock International Parkinson&#8217;s Disease (ROPAD) Study aims to [&hellip;]","og_url":"https:\/\/www.centogene.com\/zh\/centogene\u5728\u5168\u7403\u5e15\u91d1\u68ee\u75c5\u7814\u7a76\u4e2d\u8fbe\u523010000\u540d\u53c2\u4e0e\u8005\u7684\u91cc\u7a0b\u7891\/","og_site_name":"CENTOGENE","article_published_time":"2021-03-05T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"admincg","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"6 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE Reaches 10,000 Participant Milestone in Global Parkinson\u2019s Disease Study","datePublished":"2021-03-05T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\/"},"wordCount":1179,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\/","url":"https:\/\/www.centogene.com\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\/","name":"CENTOGENE\u5168\u7403\u5e15\u91d1\u68ee\u75c5\u7814\u7a76\u53c2\u4e0e\u8005\u4eba\u6570\u7a81\u78341\u4e07\u5927\u5173 | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2021-03-05T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogene-reaches-10000-participant-milestone-in-global-parkinsons-disease-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE Reaches 10,000 Participant Milestone in Global Parkinson\u2019s Disease Study"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"\u4e2d\u5fc3\u57fa\u56e0","description":"\u6307\u5bfc\u7cbe\u51c6\u533b\u7597","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"\u4e2d\u5fc3\u57fa\u56e0","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"\u7ba1\u7406\u5458","url":"https:\/\/www.centogene.com\/zh\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/posts\/2278","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/comments?post=2278"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/posts\/2278\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/media?parent=2278"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/categories?post=2278"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/tags?post=2278"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}